Detalhe da pesquisa
1.
Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study.
Rheumatology (Oxford)
; 60(4): 1915-1925, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33155024
2.
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.
Int J Clin Oncol
; 26(5): 841-850, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783657
3.
Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014.
Diabetes Obes Metab
; 22(7): 1132-1140, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32090430
4.
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases.
Adv Ther
; 39(5): 2222-2235, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316503
5.
Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis.
Adv Ther
; 37(5): 2460-2476, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32319038